Form 4: CVS Health Executive Reports Stock Transactions

CVS Health Corp. executive Prem S. Shah reported transactions involving restricted stock units and stock options.

Summary

• Prem S. Shah, EVP and Group President at CVS Health Corp., has reported several transactions related to his beneficial ownership of company securities.
• On March 31, 2026, 25,062 restricted stock units were acquired at a price of $71.82, increasing his total holdings to 62,852.
• On April 1, 2026, 1,484 shares of common stock were disposed of for $72.49 per share, resulting in a total of 64,356.0985 shares held.
• A stock option for 161,676 shares was acquired on March 31, 2026, with an exercise price of $71.82. This option becomes exercisable in three equal annual installments starting March 31, 2027, with an expiration date of March 31, 2036.
• The restricted stock units awarded under the Issuer's 2017 Incentive Compensation Plan have restrictions that lapse in three equal installments, beginning March 31, 2027.
• The disposal of 1,484 shares on April 1, 2026, was to cover withholding taxes due upon the vesting and settlement of restricted stock units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents routine executive equity transactions and compensation plan mechanics rather than significant strategic shifts or performance indicators.

Positives

• Acquisition of 25,062 restricted stock units, indicating continued equity incentive for executive leadership.
• Acquisition of a stock option for 161,676 shares, suggesting potential future upside for the executive.
• The executive's stock option and restricted stock units are structured with vesting schedules, aligning long-term incentives with company performance.

Negatives

• Surrender of 1,484 shares to cover withholding taxes, which represents a reduction in direct shareholding.

Risks

• The vesting schedule for restricted stock units and stock options means that a significant portion of these awards are not yet fully available to the executive, contingent on continued service and potentially company performance.
• The executive's beneficial ownership is subject to market fluctuations and the company's stock performance.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports on past transactions and the terms of equity awards.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for executives and directors of publicly traded companies, providing transparency into their equity transactions. This filing for CVS Health Corp. is typical for an executive receiving and managing equity-based compensation.

Stakeholder Impact

• Shareholders: Increased transparency into executive compensation and potential future dilution if options are exercised.
• Employees: The executive's compensation structure reflects standard incentive practices within the industry.
• Management: The transactions are part of the established compensation framework for senior leadership.

Next Steps

• Vesting of restricted stock units in three equal installments commencing March 31, 2027.
• Exercisability of stock options in three equal annual installments commencing March 31, 2027.

Key Dates

Keywords

CVS Health, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Beneficial Ownership, Executive Compensation, Securities Exchange Act, Prem S. Shah